New Biosimilar Approval Pathway Creates Device Opportunities
This article was originally published in The Pink Sheet Daily
Executive Summary
Several companies focusing on specialized injectors designed to improve patient comfort and compliance say their technologies will be crucial to differentiating biopharmaceutical products that are vying for the same patient population, but contain virtually the same active ingredient.